Navigating the UKB plasma proteomics
data to explore the variability of proteins, learn about disease risk scores and proteogenomic associations
Join our workshop during the Nordic Conference on Future Health as we explore the UK Biobank Pharma Proteomics Project (UKB-PPP), the world’s largest proteomics study. Discover how researchers are leveraging UKB-PPP data to find protein-disease risk associations and learn how you can integrate your Olink data with this invaluable resource.
Stay tuned for more details on our guest speaker.
Learning outcomes:
- An overview of how you can work alongside UKB-PPP data in genomics and proteomics, with examples of data mining, validation, and integration
- An introduction to freely available resources in Olink Insight to enhance study design and validation, including large sets of protein-disease risk associations and pQTLs based on UKB-PPP, as well as protein normal ranges
Date: September 10, 2024
Location: Clarion Brattøra Venue, Trondheim, Norway
Time: 10:30 - 12:00 CEST (lunch will be provided)
If you are curious to check out Olink Insight in advance, click here
Featured Speakers
Christopher Foley,
Chief Data Scientist & Managing Director, BioXcelerate AI, A Division of Optima Partners Ltd
“How AI and protein patterns are changing disease prediction”
Ola Caster
Senior Data Scientist
Olink Proteomics
Olink Proteomics
'Proteomics of disease risk in UK Biobank'
Janet Kenyon
FAS Manager, UK & Nordics
Olink Proteomics
Olink Proteomics
'Navigating data: How to work with UKB and Olink data'